CDK8/19 inhibition overcomes in vitro and in vivo resistance to lapatinib in HER2+breast cancer via STAT1 and STAT3.

被引：0
|
作者：
Ding, Xiaokai [1 ]
Sharko, Amanda C. [1 ]
McDermott, Martina S-J [1 ]
Ji, Hao [1 ]
Chumanevich, Alexander [1 ]
Schools, Gary P. [1 ]
Mack, Zachary T. [1 ]
Pugacheva, Elena [2 ]
Tatarskiy, Victor [3 ]
Khrustaleva, Anastasia [3 ]
Tyakht, Alexander [3 ]
Shtutman, Michael [1 ]
Chen, Mengqian [4 ]
Roninson, Igor [1 ]
Broude, Eugenia V. [1 ]
机构：
[1] Univ South Carolina, Coll Pharm, Columbia, SC 29208 USA
[2] West Virginia Univ, Sch Med, Morgantown, WV 26506 USA
[3] Russian Acad Sci, Inst Gene Biol, Moscow, Russia
[4] Senex Biotechnol, Columbia, SC USA
来源：
CANCER RESEARCH | 2021年 / 81卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB132
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Role of CDK8 and CDK19 in STAT1 phosphorylation at serine 727
    Li, Jing
    Liang, Jiaxin
    Wang, Lili
    Broude, Eugenia
    Roninson, Igor
    Chen, Mengqian
    CANCER RESEARCH, 2020, 80 (16)
  • [2] Soluble TNFα overcomes lapatinib resistance in HER2+breast cancer
    Bruni, Sofia
    Mauro, Florencia L.
    De Martino, Mara
    Deamicis, Agustina Roldan
    Mercogliano, Maria F.
    Schillaci, Roxana
    Elizalde, Patricia, V
    CANCER RESEARCH, 2020, 80 (16)
  • [3] Inhibition of CDK8/19 Mediator kinase potentiates HER2-targeting drugs and bypasses resistance to these agents in vitro and in vivo
    Ding, Xiaokai
    Sharko, Amanda C.
    McDermott, Martina S. J.
    Schools, Gary P.
    Chumanevich, Alexander
    Ji, Hao
    Li, Jing
    Zhang, Li
    Mack, Zachary T.
    Sikirzhytski, Vitali
    Shtutman, Michael
    Ivers, Laura
    O'Donovan, Norma
    Crown, John
    Gyorffy, Balazs
    Chen, Mengqian
    Roninson, Igor B.
    Broude, Eugenia, V
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2022, 119 (32)
  • [4] STAT6 expression and trastuzumab resistance in HER2+breast cancer.
    Cobleigh, Melody A.
    DiScala, Molly
    Najor, Matthew S.
    Yung, Timothy
    Abukhdeir, Abde M.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [5] STAT1 Gene Expression Is Enhanced by Nuclear EGFR and HER2 via Cooperation With STAT3
    Han, Woody
    Carpenter, Richard L.
    Cao, Xinyu
    Lo, Hui-Wen
    MOLECULAR CARCINOGENESIS, 2013, 52 (12) : 959 - 969
  • [6] CDK8、STAT1和TMEFF2在大肠组织中的表达及意义
    孔红祥
    王红
    广东医学, 2012, 33 (14) : 2079 - 2082
  • [7] CDK8 inhibition potentiates anti-ER and anti-HER2 therapies in breast cancer
    McDermott, Martina S.
    Lim, Chang-uk
    Chen, Mengqian
    Chumanevich, Alexander
    Catroppo, James F.
    Gyorffy, Balazs
    Oliver, David
    Roninson, Igor B.
    Broude, Eugenia V.
    CANCER RESEARCH, 2015, 75
  • [8] CDK8 inhibition improves the efficacy of ER- and HER2-targeted drugs in breast cancer
    McDermott, M. S.
    Chumanevich, A.
    Liang, J.
    Chen, M.
    Altilia, S.
    Hennes, C.
    Roninson, I. B.
    Broude, E. V.
    CANCER RESEARCH, 2017, 77
  • [9] DUSP6 inhibition overcomes neuregulin/HER3-driven therapy tolerance in HER2+breast cancer
    Momeny, Majid
    Tienhaara, Mari
    Sharma, Mukund
    Chakroborty, Deepankar
    Varjus, Roosa
    Takala, Iina
    Merisaari, Joni
    Padzik, Artur
    Vogt, Andreas
    Paatero, Ilkka
    Elenius, Klaus
    Laajala, Teemu D.
    Kurppa, Kari J.
    Westermarck, Jukka
    EMBO MOLECULAR MEDICINE, 2024, 16 (07) : 1603 - 1629
  • [10] Dual inhibition of STAT1 and STAT3 activation downregulates expression of PD-L1 in human breast cancer cells
    Nair, Varun Sasidharan
    Toor, Salman M.
    Ali, Bassam R.
    Elkord, Eyad
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2018, 22 (06) : 547 - 557
12345